Montesclaros, Angelica .
HRN: 22-12-07 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/29/2022
CEFUROXIME 500MG (TAB)
10/29/2022
11/04/2022
ORAL
500mg
BID
Thinly MSAF And Episorhaphy
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes